Exhuberance Over Exubera
Authors:
- Pamela F. HitePHPamela F. Hite
- Ann M. BarnesABAnn M. Barnes
- Philip E. JohnstonPJPhilip E. Johnston
- 1 July 2006
- journal article
- Published by American Diabetes Association in Clinical Diabetes
- Vol. 24 (3) , 110-114
Abstract
IN BRIEF The isolation, purification, and clinical use of insulin has been enhanced many times in the past 80 years. This article outlines the development of insulin and describes the formulation, activity, and practical use of a newly approved inhaled form of insulin sold under the trade name Exubera.Keywords
This publication has 12 references indexed in Scilit:
- Resurrections in Toronto: The Emergence of InsulinHormone Research in Paediatrics, 2005
- Efficacy and Safety of Inhaled Insulin (Exubera) Compared With Subcutaneous Insulin Therapy in Patients With Type 1 DiabetesDiabetes Care, 2004
- Efficacy and Safety of Inhaled Insulin (Exubera) Compared With Subcutaneous Insulin Therapy in Patients With Type 2 DiabetesDiabetes Care, 2004
- Inhaled Insulin Provides Improved Glycemic Control in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Oral AgentsA Randomized Controlled TrialArchives of internal medicine (1960), 2003
- TechnosphereTM/Insulin - proof of concept study with a new insulin formulation for pulmonary deliveryExperimental and Clinical Endocrinology & Diabetes, 2002
- Treatment Satisfaction With Inhaled Insulin in Patients With Type 1 DiabetesDiabetes Care, 2001
- A Sweet Way to Keep Proteins SafeScience, 1998
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- Mechanism of insulin aggregation and stabilization in agitated aqueous solutionsBiotechnology and Bioengineering, 1992
- Introduction1986